Sanare Lab
Science-based health education team reviewing published research on repurposed drugs, integrative oncology, and evidence-based protocols.
Long Read
fenbendazole
Fenbendazole for Cervical and Blood Cancers
Preclinical evidence for fenbendazole in cervical cancer (HeLa) and blood cancers (leukemia and lymphoma), with honest limits and real PubMed sources.
fenbendazole
Fenbendazole for Bladder Cancer: Research Review 2026
Preclinical research on fenbendazole for bladder cancer: the 2026 photothermal ferroptosis nanoplatform study, mechanisms, and honest evidence limits.
fenbendazole
Fenbendazole for Liver Cancer (Hepatocellular Carcinoma): Research Review
Does fenbendazole help hepatocellular carcinoma? A look at the preclinical anti-tumour signals, the documented liver-injury cases, and sensible monitoring.
Fenbendazole for Cancer by Type: A Research Hub (2026)
A curated research hub that groups our fenbendazole summaries by tumour type — lung, breast, prostate, brain, colorectal, pancreatic and ovarian — so you can jump straight to the mechanisms, case reports, dosing and safety notes for a specific cancer.
ivermectin
The Marik Protocol: Ivermectin and Mebendazole for Cancer — Theory, Evidence, and Risks
A careful, evidence-based review of the Marik ivermectin + mebendazole cancer protocol — the proposed theory, what the human data actually shows, the dosing claims, and the real safety risks.
fenbendazole
Fenbendazole for Melanoma: Preclinical Evidence, Case Reports and What We Know (2026)
Can fenbendazole fight melanoma? We review the preclinical evidence, mechanisms of action, and what the current cancer research actually shows.